SCA
Spearhead Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,226
| Closed | -$249K | – | 180 |
|
|
2021
Q3 | $249K | Sell |
2,226
-84
| -4% | -$9.4K | 0.03% | 175 |
|
|
2021
Q2 | $374K | Sell |
2,310
-1,396
| -38% | -$226K | 0.05% | 155 |
|
|
2021
Q1 | $452K | Buy |
3,706
+170
| +5% | +$20.7K | 0.07% | 89 |
|
|
2020
Q4 | $541K | Sell |
3,536
-601
| -15% | -$92K | 0.09% | 93 |
|
|
2020
Q3 | $346K | Sell |
4,137
-6
| -0.1% | -$502 | 0.07% | 111 |
|
|
2020
Q2 | $304K | Buy |
+4,143
| New | +$304K | 0.06% | 104 |
|